Issues related to Prescription Drug User Fee Reauthorization. Issues relating to US and international manufacturing. 340B.
2025 · 2nd Quarter (Apr 1 - June 30)
BEONE MEDICINES ( FORMERLY KNOWN AS BEIGENE USA, INC.)
Filed by WILLIAMS AND JENSEN, PLLC.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 21, 2025
- Income
- $80,000.00
- Expenses
- Not reported
- Registrant
- WILLIAMS AND JENSEN, PLLC
- Filing UUID
- 5e899285-01d1-4057-8776-929b7ea55083
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Monitoring activities related to tariffs and trade. Issues relating to US and international manufacturing.
Issues related to drug pricing and reimbursement for prescription drugs related to "Inflation Reduction Act of 2022" (PL 117-169) implementation, Subtitle J (Part B and D drug pricing). PBM coverage issue in Medicare. ORPHAN Drug Act.
Issues relating to US and international manufacturing.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.